Board Meeting5 Oct 2026, 04:19 pm
Bacil Pharma Board Meeting on Oct 14 to Approve Unaudited Financial Results
AI Summary
Bacil Pharma Ltd has announced that its Board of Directors will convene on October 14, 2026. The primary agenda item is the consideration and approval of the company's unaudited financial results for the half-yearly and quarterly period ending September 30, 2026. The meeting will also address any other business as permitted by the Chairperson.
Key Highlights
- Board meeting scheduled for October 14, 2026.
- To consider and approve unaudited financial results.
- Results for the half-yearly and quarterly period ending September 30, 2026.
- Other business may be discussed with Chairperson's permission.
Price Impact
More from BACPHAR
More in Board Meeting